The proposed book discuses most recent developments in COVID-19 pathogenesis and treatment. It addresses COVID-19 coinfection with other infectious diseases like malaria and tuberculosis and cancer and focuses on post-COVID and long-term COVID problems.
The proposed book discuses most recent developments in COVID-19 pathogenesis and treatment. It addresses COVID-19 coinfection with other infectious diseases like malaria and tuberculosis and cancer and focuses on post-COVID and long-term COVID problems.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
M. Tabish Qidwai is M. Tech and PhD graduate of the Biotechnology Engineering at the Dr. A.P.J. Abdul Kalam Technical University Lucknow, India, and an Associate Professor in the SRM University, UP, India. He previously worked as officiating Director of IBST, SRM University, Assistant Professor at BB Ambedkar University, Lucknow. He is working in the area of infectious disease since more than one decade. He is working as section editor of Current Indian Science (Bentham Science). He has been awarded with several prestigious awards and appreciation letters.
Inhaltsangabe
Part I: Current Trends in Pathophysiology and Post COVID Effects. 1. Pathophysiology of SARS-CoV-2 Tejal Shreeya Tabish Qidwai and Bhartendu Nath Mishra. 2. Investigation of Post COVID/Long COVID Complications in Humans Sukanya Tripathy Sanjay Singh Monisha Banerjee and Anand Prakash. PART II: Sars Co-V2 Co-Infection with other Pathogens. 3. Falciparum malaria and COVID-19 co-infections AashnaSrivastava Tabish Qidwai and Mariam Imam . 4. Interaction of COVID-19 and Tuberculosis Malti Dadheech and Anand Kumar Maurya. 5. Co-Infection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections Sabiha Fatima Samina Wasi Nikhat Jamal Siddiqi and Reem Hamoud Alrashoudi. Part III: Covid-19 and Neurological Complications. 6. Neurological Association of COVID-19 and Neurodegenerative Disorders Shilpa Kumari Ankit Madeshiya and Sarika Singh. PART IV: COVID-19 and Cancer. 7. Impact of COVID-19 on Cancer Care Prognosis and Immuno-Oncological Challenge of COVID-19 Atar Singh Kushwah Shireen Masood Amreen Shamsad and Monisha Banerjee. 8. Investigating the Severity of COVID-19 in Lung Cancer Patients and Current Treatment: Evidence and Challenges Saurabh Kumar Osaid Masood Shama Parveen Sanjay Saini and Monisha Banerjee. Part V: Current Therapeutic Approaches. 9. COVID-19 Therapy: Molecular Mechanisms Pharmacological Interventions and Therapeutic Targets Ruchi Chawla Mohini Mishra Krishan Kumar and Varsha Rani. 10. Exploration of Nanotherapeutics in COVID-19 Nikhat J. Siddiqi Sabiha Fathima Sooad K. AlDaihan Hanan A. Balto and Bechan Sharma. 11. Pharmacogenomics and COVID-19 Rishabh Chaudhary Divya Chaudhary and Vikas Mishra.
Part I: Current Trends in Pathophysiology and Post COVID Effects. 1. Pathophysiology of SARS-CoV-2 Tejal Shreeya Tabish Qidwai and Bhartendu Nath Mishra. 2. Investigation of Post COVID/Long COVID Complications in Humans Sukanya Tripathy Sanjay Singh Monisha Banerjee and Anand Prakash. PART II: Sars Co-V2 Co-Infection with other Pathogens. 3. Falciparum malaria and COVID-19 co-infections AashnaSrivastava Tabish Qidwai and Mariam Imam . 4. Interaction of COVID-19 and Tuberculosis Malti Dadheech and Anand Kumar Maurya. 5. Co-Infection of SARS-CoV-2 with Viruses Causing Respiratory and Systemic Infections Sabiha Fatima Samina Wasi Nikhat Jamal Siddiqi and Reem Hamoud Alrashoudi. Part III: Covid-19 and Neurological Complications. 6. Neurological Association of COVID-19 and Neurodegenerative Disorders Shilpa Kumari Ankit Madeshiya and Sarika Singh. PART IV: COVID-19 and Cancer. 7. Impact of COVID-19 on Cancer Care Prognosis and Immuno-Oncological Challenge of COVID-19 Atar Singh Kushwah Shireen Masood Amreen Shamsad and Monisha Banerjee. 8. Investigating the Severity of COVID-19 in Lung Cancer Patients and Current Treatment: Evidence and Challenges Saurabh Kumar Osaid Masood Shama Parveen Sanjay Saini and Monisha Banerjee. Part V: Current Therapeutic Approaches. 9. COVID-19 Therapy: Molecular Mechanisms Pharmacological Interventions and Therapeutic Targets Ruchi Chawla Mohini Mishra Krishan Kumar and Varsha Rani. 10. Exploration of Nanotherapeutics in COVID-19 Nikhat J. Siddiqi Sabiha Fathima Sooad K. AlDaihan Hanan A. Balto and Bechan Sharma. 11. Pharmacogenomics and COVID-19 Rishabh Chaudhary Divya Chaudhary and Vikas Mishra.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
